Home Cart 0 Sign in  

[ CAS No. 6342-56-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 6342-56-9
Chemical Structure| 6342-56-9
Structure of 6342-56-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 6342-56-9 ]

Related Doc. of [ 6342-56-9 ]

Alternatived Products of [ 6342-56-9 ]

Product Details of [ 6342-56-9 ]

CAS No. :6342-56-9 MDL No. :MFCD00008758
Formula : C5H10O3 Boiling Point : -
Linear Structure Formula :- InChI Key :ULVSHNOGEVXRDR-UHFFFAOYSA-N
M.W : 118.13 Pubchem ID :80650
Synonyms :

Calculated chemistry of [ 6342-56-9 ]

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.8
Num. rotatable bonds : 3
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 28.52
TPSA : 35.53 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.15 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.44
Log Po/w (XLOGP3) : -0.18
Log Po/w (WLOGP) : 0.19
Log Po/w (MLOGP) : -0.39
Log Po/w (SILICOS-IT) : 0.17
Consensus Log Po/w : 0.25

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.26
Solubility : 64.8 mg/ml ; 0.548 mol/l
Class : Very soluble
Log S (Ali) : -0.11
Solubility : 91.6 mg/ml ; 0.775 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.47
Solubility : 40.2 mg/ml ; 0.34 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.34

Safety of [ 6342-56-9 ]

Signal Word:Danger Class:3
Precautionary Statements:P261-P305+P351+P338 UN#:1224
Hazard Statements:H226-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 6342-56-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 6342-56-9 ]
  • Downstream synthetic route of [ 6342-56-9 ]

[ 6342-56-9 ] Synthesis Path-Upstream   1~41

  • 1
  • [ 6342-56-9 ]
  • [ 180869-36-7 ]
  • [ 74-88-4 ]
  • [ 1074-68-6 ]
Reference: [1] Patent: US2004/38971, 2004, A1,
[2] Patent: US2004/87639, 2004, A1,
[3] Patent: US2005/148610, 2005, A1,
  • 2
  • [ 6342-56-9 ]
  • [ 25746-87-6 ]
Reference: [1] Patent: US2011/98272, 2011, A1,
  • 3
  • [ 6342-56-9 ]
  • [ 104-86-9 ]
  • [ 14123-76-3 ]
Reference: [1] Journal of Medicinal Chemistry, 2014, vol. 57, # 17, p. 7412 - 7424
  • 4
  • [ 1401816-27-0 ]
  • [ 75-16-1 ]
  • [ 6342-56-9 ]
Reference: [1] Molecules, 2012, vol. 17, # 12, p. 13864 - 13878
  • 5
  • [ 67-56-1 ]
  • [ 78-98-8 ]
  • [ 6342-56-9 ]
Reference: [1] European Journal of Organic Chemistry, 2009, # 9, p. 1417 - 1426
[2] Journal of the Chemical Society, 1955, p. 3337,3339
[3] Heterocycles, 2007, vol. 74, # C, p. 211 - 218
  • 6
  • [ 67-56-1 ]
  • [ 1186-47-6 ]
  • [ 6342-56-9 ]
Reference: [1] Journal of the American Chemical Society, 1986, vol. 108, p. 7812
  • 7
  • [ 18664-32-9 ]
  • [ 6342-56-9 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1990, # 8, p. 2239 - 2243
  • 8
  • [ 1401816-27-0 ]
  • [ 917-54-4 ]
  • [ 6342-56-9 ]
Reference: [1] Molecules, 2012, vol. 17, # 12, p. 13864 - 13878
  • 9
  • [ 67-56-1 ]
  • [ 96-26-4 ]
  • [ 6342-56-9 ]
Reference: [1] ChemSusChem, 2013, vol. 6, # 8, p. 1352 - 1356
  • 10
  • [ 67-56-1 ]
  • [ 57-48-7 ]
  • [ 1917-64-2 ]
  • [ 6342-56-9 ]
  • [ 547-64-8 ]
  • [ 624-45-3 ]
Reference: [1] ChemCatChem, 2018, vol. 10, # 18, p. 4154 - 4161
  • 11
  • [ 67-56-1 ]
  • [ 57-48-7 ]
  • [ 1917-64-2 ]
  • [ 6342-56-9 ]
  • [ 547-64-8 ]
Reference: [1] ChemCatChem, 2018, vol. 10, # 18, p. 4154 - 4161
  • 12
  • [ 67-56-1 ]
  • [ 96-26-4 ]
  • [ 6342-56-9 ]
  • [ 19255-83-5 ]
Reference: [1] Chemical Communications, 2005, # 21, p. 2716 - 2718
  • 13
  • [ 67-56-1 ]
  • [ 56-82-6 ]
  • [ 6342-56-9 ]
  • [ 547-64-8 ]
Reference: [1] Chemical Communications, 2005, # 21, p. 2716 - 2718
  • 14
  • [ 67-56-1 ]
  • [ 78-98-8 ]
  • [ 6342-56-9 ]
  • [ 547-64-8 ]
Reference: [1] Chemical Communications, 2005, # 21, p. 2716 - 2718
  • 15
  • [ 67-56-1 ]
  • [ 18218-93-4 ]
  • [ 6342-56-9 ]
  • [ 19255-83-5 ]
  • [ 18218-94-5 ]
Reference: [1] Russian Chemical Bulletin, 1998, vol. 47, # 12, p. 2422 - 2425
  • 16
  • [ 67-56-1 ]
  • [ 96-26-4 ]
  • [ 6342-56-9 ]
  • [ 547-64-8 ]
Reference: [1] ChemCatChem, 2015, vol. 7, # 7, p. 1152 - 1160
[2] ChemSusChem, 2013, vol. 6, # 8, p. 1352 - 1356
[3] Chemical Communications, 2005, # 21, p. 2716 - 2718
  • 17
  • [ 27313-32-2 ]
  • [ 124-41-4 ]
  • [ 6342-56-9 ]
Reference: [1] Synthesis, 1982, # 8, p. 667 - 670
  • 18
  • [ 67-56-1 ]
  • [ 23386-92-7 ]
  • [ 6342-56-9 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1969, vol. 724, p. 128 - 136
  • 19
  • [ 67-56-1 ]
  • [ 624-67-9 ]
  • [ 6342-56-9 ]
  • [ 19255-83-5 ]
Reference: [1] Patent: DE1008276, 1955, ,
  • 20
  • [ 867-13-0 ]
  • [ 6342-56-9 ]
  • [ 62054-49-3 ]
Reference: [1] Steroids, 2002, vol. 67, # 9, p. 789 - 798
  • 21
  • [ 6342-56-9 ]
  • [ 616-38-6 ]
  • [ 60705-25-1 ]
Reference: [1] Journal of Organic Chemistry, 1977, vol. 42, p. 525 - 527
  • 22
  • [ 6342-56-9 ]
  • [ 4637-24-5 ]
  • [ 67751-23-9 ]
YieldReaction ConditionsOperation in experiment
91% at 110℃; for 3 h; 1,1-dimethoxy-N,N-dimethylmethanamine (100 g, 839 mmol, 1.02 equiv.) and 1,1-dimethoxypropan-2-one (97 g, 821 mmol) were added and stirred at 110° C. for 3 hours. The produced methanol was removed by a Dean-Stark apparatus. After the solution was cooled to room temperature, the remaining volatile materials were removed in vacuo to provide 130 g of the crude product, (E)-4-(dimethylamino)-1,1-dimethoxybut-3-en-2-one (1) (130 g, 143 g theoretical, 91percent). LC-MS m/z 283 (M+1). Reference: WO 2006/0097341A1 (incorporated by reference), pg 67.
68% for 20 h; Reflux (3E)-4-(Dimethylamino)-1,1-dimethoxybut-3-en-2-one (C10)
A solution of N,N-dimethylformamide dimethyl acetal (147 g, 1.23 mol) and 1,1-dimethoxyacetone (146 g, 1.24 mol) in 2-butanol (1 L) was heated at reflux for 20 hours.
After removal of solvent in vacuo, the residue was distilled under vacuum to provide the product as an oil. Yield: 145 g, 0.837 mol, 68percent.
Boiling point: 132-140° C./0.15 torr. NMR and MS data were obtained using the product of a reaction run under similar conditions. LCMS m/z 174.0 (M+1).
1H NMR (400 MHz, CDCl3) δ 2.77 (br s, 3H), 3.02 (br s, 3H), 3.30 (s, 6H), 4.47 (s, 1H), 5.23 (br d, J=12.6 Hz, 1H), 7.63 (d, J=12.6 Hz, 1H).
68% at 110℃; for 3 h; Inert atmosphere A stuffed solution of 1,1-dimethoxy-N,N-dimethylmethanamine (5 g, 42 mmol) was mixed with 1,1-dimethoxypropan-2-one (4.95 g, 42 mmol) under nitrogen atmosphere. The reaction mixture was heated to 110 °C for 3 h. The methanol produced was removed by Dean-Stark apparatus. After completion the solution was cooled to rt and volatiles were removed under reduced pressure to obtain oily residue. The crude material was purified by column chromatography (60-120 silica gel, 0-5percent Methanol/DCM) to afford 2.3g of the title compound (68percent). LCMS: mlz=174 [M+1]. ‘H-NMR (400MHz, CDC13) ö: 7.6 1-7.58 (d, 1H), 5.19-5.16 (d, 1H), 4.43 (s, 1H), 3.26 (s, 6H), 3.10-3.08 (d, 3H), 2.79 (s, 3H), 1.15 (s, 6H).
Reference: [1] Patent: US2012/270892, 2012, A1, . Location in patent: Page/Page column 56
[2] Patent: WO2013/2660, 2013, A2, . Location in patent: Paragraph 00145; 00146
[3] Tetrahedron, 2008, vol. 64, # 33, p. 7745 - 7758
[4] Patent: WO2004/22553, 2004, A1, . Location in patent: Page/Page column 18
[5] Patent: US2011/98272, 2011, A1, . Location in patent: Page/Page column 22
[6] Patent: WO2016/44626, 2016, A1, . Location in patent: Paragraph 00454
[7] Bioorganic and Medicinal Chemistry Letters, 1998, vol. 8, # 22, p. 3111 - 3116
[8] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 9, p. 1123 - 1126
[9] Patent: US2005/261354, 2005, A1, . Location in patent: Page/Page column 87
[10] Patent: US2008/85898, 2008, A1, . Location in patent: Page/Page column 17
[11] Patent: WO2006/26305, 2006, A1, . Location in patent: Page/Page column 32
[12] Patent: WO2006/58905, 2006, A1, . Location in patent: Page/Page column 49; 61
[13] Patent: US2011/152235, 2011, A1, . Location in patent: Page/Page column 66
[14] Patent: WO2011/103289, 2011, A2, . Location in patent: Page/Page column 72
[15] Patent: US2014/315961, 2014, A1, . Location in patent: Paragraph 0320-0321
[16] Patent: WO2015/97123, 2015, A1, . Location in patent: Page/Page column 133
[17] Patent: WO2016/207225, 2016, A1, . Location in patent: Page/Page column 34
[18] Patent: WO2016/207226, 2016, A1, . Location in patent: Page/Page column 60; 61
[19] Patent: WO2016/207217, 2016, A1, . Location in patent: Page/Page column 49-50
[20] Patent: WO2017/125224, 2017, A1, . Location in patent: Page/Page column 34
[21] Patent: CN107235982, 2017, A, . Location in patent: Paragraph 0006
  • 23
  • [ 6342-56-9 ]
  • [ 5815-08-7 ]
  • [ 67751-23-9 ]
Reference: [1] Patent: US5684011, 1997, A,
  • 24
  • [ 15206-55-0 ]
  • [ 6342-56-9 ]
  • [ 21210-43-5 ]
  • [ 20698-91-3 ]
  • [ 42919-42-6 ]
  • [ 42919-42-6 ]
Reference: [1] Catalysis Communications, 2011, vol. 12, # 15, p. 1410 - 1414
[2] Catalysis Letters, 2012, vol. 142, # 7, p. 889 - 894
[3] Catalysis Letters, 2012, vol. 142, # 7, p. 889 - 894
  • 25
  • [ 15206-55-0 ]
  • [ 6342-56-9 ]
  • [ 21210-43-5 ]
  • [ 20698-91-3 ]
  • [ 42919-42-6 ]
Reference: [1] Catalysis Communications, 2011, vol. 12, # 15, p. 1410 - 1414
[2] Catalysis Letters, 2012, vol. 142, # 7, p. 889 - 894
  • 26
  • [ 6342-56-9 ]
  • [ 111573-59-2 ]
Reference: [1] European Journal of Medicinal Chemistry, 1993, vol. 28, # 2, p. 129 - 140
[2] Patent: CN107235982, 2017, A,
  • 27
  • [ 6342-56-9 ]
  • [ 4637-24-5 ]
  • [ 111573-59-2 ]
Reference: [1] Chinese Journal of Catalysis, 2016, vol. 37, # 9, p. 1446 - 1450
  • 28
  • [ 6342-56-9 ]
  • [ 50-01-1 ]
  • [ 4637-24-5 ]
  • [ 165807-05-6 ]
YieldReaction ConditionsOperation in experiment
70%
Stage #1: at 110℃; for 15 h;
Stage #2: With sodium hydroxide In water; N,N-dimethyl-formamide at 110℃; for 36 h;
Pyruvic aldehyde dimethyl acetal (10 g, 84 mmol) and N, N’-dimethyl formamide dimethyl diacetal (10 g, 84 mmol) in DMF (30 ml) were heated in a round bottom flask at 110 °C for 15 h. Guanidine hydrochloride (12 g, 127 mmol) and NaOH (6.7 g, 169 mmol) in water were then added to the reaction mixture. The mixture was refluxed for further 36 h. The reaction mass was then cooled and filtered. The product was recrystallized from hot ethyl acetate to yield white crystalline solid 2 (10 g, 70percent).
36%
Stage #1: at 100℃; for 16 h;
Stage #2: With sodium hydroxide In water at 20℃; for 48 h;
Procedure H: Intermediate 8 (1-8) - 2-Aminopyrimidine-4-carboxaldehyde dimethylacetal.; [0093] A solution of 5.5 mL (41 mmol, 1.0 eq.) of dimethylformamide dimethyl acetal and 5.0 mL (41 mmol, 1.0 eq.) pyruvric aldehyde dimethyl acetal was heated at 100 0C for 16 h. Methanol was removed in vacuo to afford a brown oil. A solution of 1.8 g (45 mmol, 1.1 eq.) of sodium hydroxide in 5 mL of water was added to a solution of 4.3 g (45 mmol, 1.1 eq.) of guanidine HCl in 10 mL of water. The resulting solution was added to the above described oil. The resulting mixture was stirred at room temperature for 48 h. The mixture was filtered to provide 2.5 g (15 <n="38"/>mmol, 36percent) of 2-aminopyrimidine-4-carboxaldehyde dimethyl acetal (1-8).
50% With sodium hydroxide In water a)
2-Aminopyrimidine-4-carboxaldehyde dimethyl acetal
Dimethylformamide dimethyl acetal (55 mL, 0.41 mol), and pyruvic aldehyde dimethyl acetal (50 mL, 0.41 mol) were combined and heated to 100° for 18 h.
Methanol was removed in vacuo to afford an oil.
A solution of NaOH (18 g, 0.45 mol) in H2 O (50 mL) was added to guanidine HCl (43 g, 0.45 mol) in H2 O (100 mL), and the resulting solution was added to the above described oil.
The resulting mixture was stirred at 23° for 48 h.
Filtration afforded 25 g (50percent) of the title compound.
Reference: [1] Tetrahedron Letters, 2013, vol. 54, # 28, p. 3715 - 3717
[2] Patent: EP1227092, 2002, A2, . Location in patent: Page 25
[3] Patent: EP1229035, 2002, A1, . Location in patent: Page 25
[4] Patent: EP1227091, 2002, A2, . Location in patent: Page 25
[5] Patent: WO2007/104053, 2007, A2, . Location in patent: Page/Page column 36-37
[6] Patent: US5593992, 1997, A,
[7] Patent: US5670527, 1997, A,
  • 29
  • [ 6342-56-9 ]
  • [ 165807-05-6 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 1998, vol. 8, # 22, p. 3111 - 3116
[2] Patent: WO2015/97123, 2015, A1,
  • 30
  • [ 6342-56-9 ]
  • [ 7732-18-5 ]
  • [ 4637-24-5 ]
  • [ 180869-36-7 ]
YieldReaction ConditionsOperation in experiment
93% With sodium methylate; thiourea; methyl iodide In methanol a
2-Methylthiopyrimidine-4-carboxaldehyde dimethyl acetal
Pyruvaldehyde dimethyl acetal (19.2 mL, 159.1 mmol) and N,N-dimethylformamide dimethyl acetal (21.12 mL, 159.1 mmol) were combined in a 500 mL flask and heated at 100° C.
After 4.5 h the flask was removed from the heat, thiourea (11.0 g, 144.5 mmol), NaOMe (25 wt. percent solution in MeOH, 39.7 mL, 173 mmol) and 30 mL of MeOH were added and heating was continued at 65° C.
After 18 h the solution was cooled to 25° C. and MeI (10.8 mL, 173 mmol) was added over 5 min (exothermic).
After 3 h, the solution was diluted with 250 mL of H2 O and extracted with EtOAc (3*100 mL).
The organics were combined, dried over Na2 SO4 and concentrated to give the title compound (26.8 g, 93percent) as a brown oil.
93% With sodium methylate; thiourea; methyl iodide In methanol a)
2-Methylthiopyrimidine-4-carboxaldehyde dimethyl acetal
Pyruvaldehyde dimethyl acetal (19.2 mL, 159.1 mmol) and N,N-dimethylformamide dimethyl acetal (21.12 mL, 159.1 mmol) were combined in a 500 mL flask and heated at 100° C.
After 4.5 h the flask was removed from the heat, thiourea (11.0 g, 144.5 mmol), NaOMe (25 wt. percent solution in MeOH, 39.7 mL, 173 mmol) and 30 mL of MeOH were added and heating was continued at 65° C.
After 18 h the solution was cooled to 25° C. and MeI (10.8 mL, 173 mmol) was added over 5 min (exothermic).
After 3 h, the solution was diluted with 250 mL of H2 O and extracted with EtOAc (3 X 100 mL).
The organics were combined, dried over Na2 SO4 and concentrated to give the title compound (26.8 g, 93percent) as a brown oil.
93% With sodium methylate; thiourea; methyl iodide In methanol a)
2-Methylthiopyrimidine-4-carboxaldehyde dimethyl acetal
Pyruvaldehyde dimethyl acetal (19.2 mL, 159.1 mmol) and N,N-dimethylformamide dimethyl acetal (21.12 mL, 159.1 mmol) were combined in a 500 mL flask and heated at 100° C.
After 4.5 h the flask was removed from the heat, thiourea (11.0 g, 144.5 mmol), NaOMe (25 wt. percent solution in MeOH, 39.7 mL, 173 mmol) and 30 mL of MeOH were added and heating was continued at 65° C.
After 18 h the solution was cooled to 25° C. and MeI (10.8 mL, 173 mmol) was added over 5 min (exothermic).
After 3 h, the solution was diluted with 250 mL of H2 O and extracted with EtOAc (3*100 mL).
The organics were combined, dried over Na2 SO4 and concentrated to give the title compound (26.8 g, 93percent) as a brown oil.
93% With sodium methylate; thiourea; methyl iodide In methanol a
2-Methylthiopyrimidine-4-carboxaldehyde dimethyl acetal
Pyruvaldehyde dimethyl acetal (19.2 mL, 159.1 mmol) and N,N-dimethylformamide dimethyl acetal (21.12 mL, 159.1 mmol) were combined in a 500 mL flask.
After heating at 100° C. 4.5 h, thiourea (11.0 g, 144.5 mmol), NaOMe (25 wt. percent solution in MeOH, 39.7 mL, 173 mmol) and 30 mL of MeOH were added and heating was continued at 65° C.
After 18 h, the solution was cooled to 25° C. and MeI (10.8 mL, 173 mmol) was added over 5 min (exothermic).
After 3 h, the solution was diluted with 250 mL of H2 O and extracted with EtOAc (3*100 mL).
The organics were combined, dried (Na2 SO4) and concentrated to give the title compound (26.8 g, 93percent) as a brown oil.

Reference: [1] Patent: US5593991, 1997, A,
[2] Patent: US5593992, 1997, A,
[3] Patent: US5670527, 1997, A,
[4] Patent: US5739143, 1998, A,
[5] Patent: US5658903, 1997, A,
  • 31
  • [ 6342-56-9 ]
  • [ 4637-24-5 ]
  • [ 74-88-4 ]
  • [ 180869-36-7 ]
YieldReaction ConditionsOperation in experiment
82% With sodium methylate; thiourea In methanol a
2-Methylthiopyrimidine-4-carboxaldehyde dimethyl acetal
Pyruvic aldehyde dimethyl acetal (60 mL, 459 mmol) and N,N-dimethyl formamide dimethyl acetal (60 mnL, 459 mmol) were stirred together at 100° C. for 18 h.
The mixture was cooled.
Methanol (300 mL), thiourea (69.6 g) and sodium methoxide (231 mL, 25 wt percent in MeOH) were added to the above mixture and stirred at 70° C. for 2 h.
After cooling, iodomethane (144 mL) was added dropwise and the mixture was stirred 3 h. at room temp.
After diluting with EtOAc and H2 O, the organic phase was separated, dried (Na2 SO4),and concentrated to yield the title compound as a brown oil (75.5 g, 82percent yield).
1 H NMR (CDCl3): d 8.17 (d, 1H), 6.77 (d, 1H), 5.15 (s, 1H), 3.40 (s, 6H).
82% With sodium methylate; thiourea In methanol a
2-Methylthiopyrimidine-4-carboxaldehyde dimethyl acetal
Pyruvic aldehyde dimethyl acetal (60 milliliter (hereinafter "mL"), 459 millimole (hereinafter "mmol")) and N,N-dimethyl formamide dimethyl acetal (60 mL, 459 mmol) were stirred together at 100° C. for 18 hours (hereinafter "h").
The mixture was cooled.
Methanol (300 mL), thiourea (69.6 g) and sodium methoxide (231 mL, 25 wt percent in MeOH) were added to the above mixture and stirred at 70° C. for 2 h.
After cooling, iodomethane (144 mL) was added dropwise and the mixture was stirred 3 h. at room temp.
After diluting with EtOAc and H2 O, the organic phase was separated, dried (Na2 SO4), and concentration to yield the title compound as a brown oil (75.5 gram (hereinafter "g"), 82percent yield).
1 H NMR (CDCl3): d 8.17 (d, 1H), 6.77 (d, 1H), 5.15 (s, 1H), 3.40 (s, 6H).
82% With sodium methylate; thiourea In methanol a
2-Methylthiopyrimidine-4-carboxaldehyde dimethyl acetal
Pyruvic aldehyde dimethyl acetal (60 mL, 459 mmol) and N,N-dimethyl formamide dimethyl acetal (60 mL, 459 mmol) were stirred together at 100° C. for 18 h.
The mixture was cooled.
Methanol (300 mL), thiourea (69.6 g) and sodium methoxide (231 mL, 25 wt percent in MeOH) were added to the above mixture and stirred at 70° C. for 2 h.
After cooling, iodomethane (144 mL) was added dropwise and the mixture was stirred 3 h. at room temp.
After diluting with EtOAc and H2 O, the organic phase was separated, dried (Na2 SO4),and concentrated to yield the title compound as a brown oil (75.5 g, 82percent yield).
1 H NMR (CDCl3): d 8.17 (d, 1H), 6.77 (d, 1H), 5.15 (s, 1H), 3.40 (s, 6H).
Reference: [1] Patent: US5977103, 1999, A,
[2] Patent: US6046208, 2000, A,
[3] Patent: US5756499, 1998, A,
  • 32
  • [ 6342-56-9 ]
  • [ 4637-24-5 ]
  • [ 180869-36-7 ]
YieldReaction ConditionsOperation in experiment
93% With sodium methylate; thiourea; methyl iodide In methanol; water a)
2-Methylthiopyrimidine-4-carboxaldehyde dimethyl acetal
Pyruvaldehyde dimethyl acetal (19.2 mL, 159.1 mmol) and N,N-dimethylformamide dimethyl acetal (21.12 mL, 159.1 mmol) were combined in a 500 mL flask.
After heating at 100° C. 4.5 h, thiourea (11.0 g, 144.5 mmol), NaOMe (25 wt. percent solution in MeOH, 39.7 mL, 173 mmol) and 30 mL of MeOH were added and heating was continued at 65° C.
After 18 h, the solution was cooled to 25° C. and MeI (10.8 mL, 173 mmol) was added over 5 min (exothermic).
After 3 h, the solution was diluted with 250 mL of H2O and extracted with EtOAc (3*100 mL).
The organics were combined, dried (Na2SO4) and concentrated to give the title compound (26.8 g, 93percent) as a brown oil.
Reference: [1] Patent: US6218537, 2001, B1,
  • 33
  • [ 6342-56-9 ]
  • [ 4637-24-5 ]
  • [ 17356-08-0 ]
  • [ 74-88-4 ]
  • [ 180869-36-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2015, vol. 58, # 3, p. 1067 - 1088
[2] Patent: WO2016/7966, 2016, A2, . Location in patent: Paragraph 0024
[3] Patent: US2003/225082, 2003, A1, . Location in patent: Page 8-9
  • 34
  • [ 6342-56-9 ]
  • [ 74-88-4 ]
  • [ 180869-36-7 ]
Reference: [1] Patent: US2005/113392, 2005, A1, . Location in patent: Page/Page column 19-20
  • 35
  • [ 6342-56-9 ]
  • [ 180869-36-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 9, p. 1123 - 1126
[2] Bioorganic and Medicinal Chemistry Letters, 1998, vol. 8, # 22, p. 3111 - 3116
[3] Patent: WO2011/103289, 2011, A2,
[4] Patent: US2012/270892, 2012, A1,
[5] Patent: WO2015/97123, 2015, A1,
[6] Patent: WO2016/207226, 2016, A1,
[7] Patent: US2011/152235, 2011, A1,
[8] Journal of Medicinal Chemistry, 2018,
  • 36
  • [ 6342-56-9 ]
  • [ 22661-87-6 ]
  • [ 4637-24-5 ]
  • [ 180869-38-9 ]
Reference: [1] Patent: WO2007/104053, 2007, A2, . Location in patent: Page/Page column 37-38
  • 37
  • [ 6342-56-9 ]
  • [ 180869-38-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 1998, vol. 8, # 22, p. 3111 - 3116
[2] Patent: WO2015/97123, 2015, A1,
  • 38
  • [ 7521-41-7 ]
  • [ 6342-56-9 ]
  • [ 204452-90-4 ]
YieldReaction ConditionsOperation in experiment
84% With sodium hydroxide In ethanol; water at 6 - 20℃; for 1 h; To a cold (6°C) solution of 2-amino-3-formylpyridine 1-3 (40 g, 0.3 16 mol), ethanol (267 ml), water (41 ml), and pyruvic aldehyde dimethyl acetal (51.3 ml, 0.411 mol) was added 5 M NaOH (82.3 ml, 0.4 11 mol) at a rate such that the internal temperature was lowerthan 20°C. After stirring at ambient temperature for 1 hour, the ethanol was removed under vacuum, and iPAc (100 mL) and NaC1 (55 g) were added. The layers were separated and the aqueous layer was extracted with iPAc (2 x 100 ml). The organic layers were combined, filtered through a silica gel bed (90 g), followed by rinse with iPAc (1 L). The fractions were combined and concentrated to 200 ml at 3 8°C. To the solution was slowly added hexane (400 ml). Theresulting suspension was cooled to 10°C and aged for 30 mm before filtration. The suspension was filtered and dried under vacuum to give the product 1-4 (54.2 g; 84percent) as colorless crystals; m.p. 53.5-55.5°C. To the mother liquors was added additional hexane (100 mL), and another 7.2 g (11percent) of 1-4 was isolated after filtration.‘H NIVIR (300 MHz; CDC13): ö 8.89 (dd, J= 4.3 and 2.0 Hz, 1H), 8.03 (d, J= 8.4 Hz, 1H), 7.98(dd, J= 8.1 and 2.0 Hz, 1H), 7.56 (d, J= 8.4 Hz, 1H), 7.26 (dd, J= 8.1 and 4.3 Hz, 1H), 5.28 (s,1H), and 3.30 (s, 6H).‘3CNI\’IR(75.5 IVIHz; CDC13): ö 161.3, 155.0, 153.5, 137.9, 136.8, 122.5, 122.3, 119.4, 105.9, and 54.9.
Reference: [1] The Journal of organic chemistry, 2004, vol. 69, # 6, p. 1959 - 1966
[2] Patent: WO2016/154369, 2016, A1, . Location in patent: Page/Page column 18
[3] Patent: US2008/269225, 2008, A1, . Location in patent: Page/Page column 37
[4] Patent: US2003/229079, 2003, A1, . Location in patent: Page 36
[5] Patent: WO2007/79214, 2007, A2, . Location in patent: Page/Page column 102
[6] Patent: US2015/119385, 2015, A1, . Location in patent: Paragraph 0570
[7] Patent: WO2015/59668, 2015, A1, . Location in patent: Page/Page column 78; 79
[8] Patent: WO2016/151501, 2016, A1, . Location in patent: Page/Page column 52
[9] Patent: WO2016/151500, 2016, A1, . Location in patent: Page/Page column 24
  • 39
  • [ 6342-56-9 ]
  • [ 204452-91-5 ]
Reference: [1] The Journal of organic chemistry, 2004, vol. 69, # 6, p. 1959 - 1966
[2] Patent: US2015/119385, 2015, A1,
[3] Patent: WO2015/59668, 2015, A1,
[4] Patent: WO2016/151501, 2016, A1,
[5] Patent: WO2016/151500, 2016, A1,
  • 40
  • [ 7521-41-7 ]
  • [ 6342-56-9 ]
  • [ 204452-91-5 ]
Reference: [1] Patent: WO2016/154369, 2016, A1,
  • 41
  • [ 6342-56-9 ]
  • [ 874279-26-2 ]
Reference: [1] Patent: WO2015/97123, 2015, A1,
[2] Patent: WO2016/207226, 2016, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 6342-56-9 ]

Aliphatic Chain Hydrocarbons

Chemical Structure| 51673-84-8

[ 51673-84-8 ]

2,2-Dimethoxyacetaldehyde

Similarity: 0.77

Chemical Structure| 21983-72-2

[ 21983-72-2 ]

3,3-Dimethoxybutan-2-one

Similarity: 0.73

Chemical Structure| 5436-21-5

[ 5436-21-5 ]

4,4-Dimethoxybutan-2-one

Similarity: 0.67

Chemical Structure| 18664-32-9

[ 18664-32-9 ]

1,3-Dimethoxypropan-2-one

Similarity: 0.65

Chemical Structure| 102-52-3

[ 102-52-3 ]

1,1,3,3-Tetramethoxypropane

Similarity: 0.65

Ethers

Chemical Structure| 51673-84-8

[ 51673-84-8 ]

2,2-Dimethoxyacetaldehyde

Similarity: 0.77

Chemical Structure| 21983-72-2

[ 21983-72-2 ]

3,3-Dimethoxybutan-2-one

Similarity: 0.73

Chemical Structure| 5436-21-5

[ 5436-21-5 ]

4,4-Dimethoxybutan-2-one

Similarity: 0.67

Chemical Structure| 18664-32-9

[ 18664-32-9 ]

1,3-Dimethoxypropan-2-one

Similarity: 0.65

Chemical Structure| 102-52-3

[ 102-52-3 ]

1,1,3,3-Tetramethoxypropane

Similarity: 0.65

Ketones

Chemical Structure| 21983-72-2

[ 21983-72-2 ]

3,3-Dimethoxybutan-2-one

Similarity: 0.73

Chemical Structure| 74181-34-3

[ 74181-34-3 ]

2,2-Dimethyl-1,3-dioxan-5-one

Similarity: 0.71

Chemical Structure| 5436-21-5

[ 5436-21-5 ]

4,4-Dimethoxybutan-2-one

Similarity: 0.67

Chemical Structure| 18664-32-9

[ 18664-32-9 ]

1,3-Dimethoxypropan-2-one

Similarity: 0.65

Chemical Structure| 10495-09-7

[ 10495-09-7 ]

Ethyl 4,4-diethoxy-3-oxobutanoate

Similarity: 0.61